Cassandra Willyard. Show Affiliations »
Abstract
Mesh: See more » Azepines/adverse effectsAzepines/classificationAzepines/pharmacologyAzepines/therapeutic useClinical Trials as TopicHumansIntracellular Signaling Peptides and Proteins/antagonists & inhibitorsIntracellular Signaling Peptides and Proteins/metabolismNeuropeptides/antagonists & inhibitorsNeuropeptides/metabolismOrexinsPatient SafetySleep/drug effectsSleep/physiologySleep Initiation and Maintenance Disorders/drug therapySleep Initiation and Maintenance Disorders/physiopathologyTriazoles/adverse effectsTriazoles/classificationTriazoles/pharmacologyTriazoles/therapeutic useUnited StatesUnited States Food and Drug Administration/legislation & jurisprudence
Substances: See more » AzepinesIntracellular Signaling Peptides and ProteinsNeuropeptidesOrexinsTriazolessuvorexant
Year: 2012 PMID: 22772537 DOI: 10.1038/nm0712-996
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440